ARCHIVES

FASEB: Focus on Research Funding, Not PR

This article is from The Cancer Letter archive.

Vol. 39 No. 24 | June 14, 2013

Download PDF Visit The Full Archive

Related Articles

List Of NCI Divisions, Addresses And Telephone Numbers

October 13, 1995

City of Hope Selects Michael Friedman As President, CEO

May 16, 2003

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

September 10, 1976

Prevention & Control Study Section Needed: Letter to the Editor

June 11, 1993

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

July 28, 1989

In Brief: NIH Study Finds Intramural Program Tenures Few Minorities, Calls For Improvements

March 11, 1994